Schinus terebinthifolius administration prevented behavioral and biochemical alterations in a rotenone model of Parkinson's disease

被引:10
|
作者
Sereniki, Adriana [1 ]
Linard-Medeiros, Cybelle F. B. [1 ]
Silva, Shirliane N. [2 ]
Silva, Juciene B. R. [1 ]
Peixoto Sobrinho, Tadeu J. S. [2 ]
da Silva, Juliano R. [1 ]
Alves, Lariza D. S. [1 ]
Smaili, Soraya S. [3 ]
Wanderley, Almir G. [1 ,2 ]
Lafayette, Simone S. L. [1 ,2 ]
机构
[1] Univ Fed Pernambuco, Dept Ciencias Farmaceut, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Fisiol & Farmacol, Recife, PE, Brazil
[3] Univ Fed Sao Paulo, Dept Farmacol, Sao Paulo, SP, Brazil
关键词
Antioxidant effects; Lipidic peroxidation; Parkinson's disease; Rotenone; Schinus terebinthifolius; ALPHA-SYNUCLEIN AGGREGATION; TEA POLYPHENOLS; ANTIOXIDANT; RAT; MECHANISMS; INJURY; DAMAGE; BRAIN; ACID;
D O I
10.1016/j.bjp.2015.11.005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Parkinson's disease is a neurodegenerative disorder characterized by motor impairment, cognitive decline and psychiatric symptoms. Schinus terebinthifolius Raddi, Anacardiaceae, had been studied for its anti-inflammatory and antioxidant properties, and in this study, the stem bark was evaluated for the neuroprotective effects on behavioral and biochemical alterations induced by administrations of rotenone in rats. Behavioral evaluations were performed using open-field and rotarod. The in vitro and in vivo antioxidant activities were determined by the DPPH radical scavenging activity and lipid peroxidation method respectively. The administration of rotenone (3 mg/kg, s.c.) produced hypolocomotion, increase of immobility and muscle incoordination, while the treatment with S. terebinthifolius stem bark extract (150, 300 and 600 mg/kg p.o.) for seven days prevented rotenone-induced dysfunctional behavior. Biochemical analysis of the substantia nigra, striatum and cortex revealed that rotenone administration significantly increased lipid peroxidation, which was inhibited by treatment with all doses of S. terebinthifolius. The results suggested neuroprotective effect of S. terebinthifolius possibly mediated through its antioxidant activity, indicating a potential therapeutic benefit of this species in the treatment of Parkinson's disease. (C) 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 50 条
  • [1] Schinus terebinthifolius administration prevented behavioral and biochemical alterations in a rotenone model of Parkinson’s disease
    Adriana Serenilo
    Cybelle F. B. Linard-Medeiros
    Shirliane N. Silva
    Juciene B. R. Silva
    Tadeu J. S. Peixoto Sobrinho
    Juliano R. da Silva
    Lariza D. S. Alves
    Soraya S. Smaili
    Almir G. Wanderley
    Simone S. L. Lafayette
    Revista Brasileira de Farmacognosia, 2016, 26 : 240 - 245
  • [2] Curcumin prevented electrophysiological and behavioral alterations in a rotenone model of Parkinson's disease
    Darbinyan, L.
    Hambardzumyan, L.
    Manukyan, L.
    Simonyan, K.
    Sarkisian, V.
    MOVEMENT DISORDERS, 2022, 37 : S614 - S614
  • [3] Behavioral alterations in rotenone model of Parkinson's disease: Attenuation by co-treatment of centrophenoxine
    Nehru, Bimla
    Verma, Ranjeet
    Khanna, Pooja
    Sharma, Suresh Kumar
    BRAIN RESEARCH, 2008, 1201 : 122 - 127
  • [4] Melatonin Improves Behavioral and Biochemical Outcomes in a Rotenone-Induced Rat Model of Parkinson's Disease
    Rasheed, Md Zeeshan
    Andrabi, Syed Suhail
    Salman, Mohd
    Tabassum, Heena
    Shaquiquzzaman, Mohammad
    Parveen, Sabiha
    Parvez, Suhel
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2018, 37 (02) : 139 - 150
  • [5] Animal model of Parkinson's disease induced by chronic administration of rotenone
    Kobayashi, Yuka
    Inden, Masatoshi
    Kitamura, Yoshihisa
    Taniguchi, Takashi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 : 124 - 126
  • [6] Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease
    Kurosaki, R
    Muramatsu, Y
    Kato, H
    Araki, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 78 (01) : 143 - 153
  • [7] The rotenone model of Parkinson's disease
    Perier, C
    Bové, J
    Vila, M
    Przedborski, S
    TRENDS IN NEUROSCIENCES, 2003, 26 (07) : 345 - 346
  • [8] Sequential Changes in Behavioral and Biochemical Parameters in Rotenone Induced Parkinson's Disease Model: Therapeutic Potentials of Vitamin E
    Sharma, N.
    Nehru, B.
    MOVEMENT DISORDERS, 2010, 25 : S636 - S636
  • [9] Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease
    Johnson, Michaela E.
    Stringer, Andrea
    Bobrovskaya, Larisa
    NEUROTOXICOLOGY, 2018, 65 : 174 - 185
  • [10] Rotenone-induced alterations in mice: A suitable animal model of Parkinson's disease?
    Richter, F
    Hamann, M
    Richter, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R79 - R79